| Authored | 1 |
| Substantive (25+ words) | 1 |
| Threads posted in | 1 |
| Distinct active days | 1 |
| Words authored | 694 |
| Received (incl. group broadcast) | 5 |
Received counts include every message sent to a channel this person belonged to. That measures presence, not participation.
2 sentences were extracted and attributed to this person. Most are not their own opinion. Reporting the total as “2 statements” would misrepresent them.
| Person | Medium | Msgs | Span |
|---|---|---|---|
| Francis S. Collins | 24 | 2018-01-01 – 2018-05-27 | |
| Lawrence A. Tabak | 5 | 2018-05-25 – 2018-05-25 | |
| Anthony S. Fauci | 2 | 2018-05-25 – 2018-05-25 | |
| Robert Eiss | 2 | 2018-05-25 – 2018-05-25 | |
| Anthony | 1 | 2018-05-25 – 2018-05-25 | |
| Anthony | 1 | 2018-05-25 – 2018-05-25 | |
| Eiss | 1 | 2018-05-25 – 2018-05-25 | |
| Eiss | 1 | 2018-05-25 – 2018-05-25 | |
| Garbarini | 1 | 2018-05-25 – 2018-05-25 | |
| Garbarini | 1 | 2018-05-25 – 2018-05-25 | |
| Glass | 1 | 2018-05-25 – 2018-05-25 | |
| Glass | 1 | 2018-05-25 – 2018-05-25 | |
| Kilmarx | 1 | 2018-05-25 – 2018-05-25 | |
| Kilmarx | 1 | 2018-05-25 – 2018-05-25 | |
| Lauer | 1 | 2018-05-25 – 2018-05-25 | |
| Lauer | 1 | 2018-05-25 – 2018-05-25 | |
| Lawrence | 1 | 2018-05-25 – 2018-05-25 | |
| Lawrence | 1 | 2018-05-25 – 2018-05-25 | |
| Michael | 1 | 2018-05-25 – 2018-05-25 | |
| Michael | 1 | 2018-05-25 – 2018-05-25 | |
| Nicole | 1 | 2018-05-25 – 2018-05-25 | |
| Nicole | 1 | 2018-05-25 – 2018-05-25 | |
| Peter | 1 | 2018-05-25 – 2018-05-25 | |
| Peter | 1 | 2018-05-25 – 2018-05-25 | |
| Robert | 1 | 2018-05-25 – 2018-05-25 |
Showing: own voice, substantive needs context quoted / not their view all
Larry, Not sure if this is relevant, but I believe FNIH still has some collaborations with BMGF, which are somewhat independent of NIH, although some may also overlap with Grand Challenges.
Gates Package, p.417 · original PDF · in context
Acting Chief of Staff and Associate Director for Science Policy Office of the Director National Institutes of Health Select Recent Highlights NIH-Bill & Melinda Gates Foundation Cooperation • Efficacy studies of two HIV vaccines moving forward o The P5 vaccine efficacy study (HVTN 702), which launched in November 2016 in South Africa, is the first HIV vaccine efficacy study in 7 years o The Imbokodo (HVTN 705) study, which launched in November 2017, is a Phase 2b proof-of-concept study evaluating the safety and efficacy of a Ad26 mosaic vaccine and Clade C gp140.
Gates Package, p.417 · original PDF · in context